188 related articles for article (PubMed ID: 26608553)
1. Synthesis, characterization and biological evaluation of anti-cancer indolizine derivatives via inhibiting β-catenin activity and activating p53.
Moon SH; Jung Y; Kim SH; Kim I
Bioorg Med Chem Lett; 2016 Jan; 26(1):110-3. PubMed ID: 26608553
[TBL] [Abstract][Full Text] [Related]
2. Biological evaluation of indolizine-chalcone hybrids as new anticancer agents.
Park S; Kim EH; Kim J; Kim SH; Kim I
Eur J Med Chem; 2018 Jan; 144():435-443. PubMed ID: 29288944
[TBL] [Abstract][Full Text] [Related]
3. Studies on indolizines. Evaluation of their biological properties as microtubule-interacting agents and as melanoma targeting compounds.
Ghinet A; Abuhaie CM; Gautret P; Rigo B; Dubois J; Farce A; Belei D; Bîcu E
Eur J Med Chem; 2015 Jan; 89():115-27. PubMed ID: 25462232
[TBL] [Abstract][Full Text] [Related]
4. Discovery of indolizines containing triazine moiety as new leads for the development of antitumoral agents targeting mitotic events.
Lucescu L; Ghinet A; Belei D; Rigo B; Dubois J; Bîcu E
Bioorg Med Chem Lett; 2015 Sep; 25(18):3975-9. PubMed ID: 26227778
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antiproliferative activity of indolizine derivatives incorporating a cyclopropylcarbonyl group against Hep-G2 cancer cell line.
Shen YM; Lv PC; Chen W; Liu PG; Zhang MZ; Zhu HL
Eur J Med Chem; 2010 Jul; 45(7):3184-90. PubMed ID: 20304535
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of phenanthroindolizidine alkaloids and evaluation of their antitumor activities and toxicities.
Ikeda T; Yaegashi T; Matsuzaki T; Yamazaki R; Hashimoto S; Sawada S
Bioorg Med Chem Lett; 2011 Oct; 21(19):5978-81. PubMed ID: 21865039
[TBL] [Abstract][Full Text] [Related]
7. Ethyl benzoate bearing pyrrolizine/indolizine moieties: Design, synthesis and biological evaluation of anti-inflammatory and cytotoxic activities.
Attalah KM; Abdalla AN; Aslam A; Ahmed M; Abourehab MAS; ElSawy NA; Gouda AM
Bioorg Chem; 2020 Jan; 94():103371. PubMed ID: 31708230
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and biological evaluation of imidazoline derivatives as p53-MDM2 binding inhibitors.
Hu C; Li X; Wang W; Zhang L; Tao L; Dong X; Sheng R; Yang B; Hu Y
Bioorg Med Chem; 2011 Sep; 19(18):5454-61. PubMed ID: 21855354
[TBL] [Abstract][Full Text] [Related]
9. New indolizines with phenanthroline skeleton: Synthesis, structure, antimycobacterial and anticancer evaluation.
Danac R; Al Matarneh CM; Shova S; Daniloaia T; Balan M; Mangalagiu II
Bioorg Med Chem; 2015 May; 23(10):2318-27. PubMed ID: 25882524
[TBL] [Abstract][Full Text] [Related]
10. Anticancer activity of novel pyrido[2,3-b]indolizine derivatives: the relevance of phenolic substituents.
Boot A; Brito A; VAN Wezel T; Morreau H; Costa M; Proença F
Anticancer Res; 2014 Apr; 34(4):1673-7. PubMed ID: 24692696
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, topoisomerase-targeting activity and growth inhibition of lycobetaine analogs.
Baechler SA; Fehr M; Habermeyer M; Hofmann A; Merz KH; Fiebig HH; Marko D; Eisenbrand G
Bioorg Med Chem; 2013 Feb; 21(3):814-23. PubMed ID: 23266176
[TBL] [Abstract][Full Text] [Related]
12. Tyrosine phosphorylation of β-catenin affects its subcellular localization and transcriptional activity of β-catenin in Hela and Bcap-37 cells.
Qian HY; Zhang DG; Wang HW; Pei DS; Zheng JN
Bioorg Med Chem Lett; 2014 Jun; 24(11):2565-70. PubMed ID: 24759800
[TBL] [Abstract][Full Text] [Related]
13. Selective recognition of DNA parallel G-quadruplexes by 3,8a-disubstituted indolizinones.
Zhang JT; Wang LX; Yang FM; Yang L; Liu Y; Tang YL
Bioorg Med Chem; 2021 Jan; 29():115848. PubMed ID: 33189508
[TBL] [Abstract][Full Text] [Related]
14. Domino Knoevenagel condensation/intramolecular aldol cyclization route to diverse indolizines with densely functionalized pyridine units.
Kim M; Jung Y; Kim I
J Org Chem; 2013 Oct; 78(20):10395-404. PubMed ID: 24067193
[TBL] [Abstract][Full Text] [Related]
15. Discovery and investigation of anticancer ruthenium-arene Schiff-base complexes via water-promoted combinatorial three-component assembly.
Chow MJ; Licona C; Yuan Qiang Wong D; Pastorin G; Gaiddon C; Ang WH
J Med Chem; 2014 Jul; 57(14):6043-59. PubMed ID: 25023617
[TBL] [Abstract][Full Text] [Related]
16. First synthesis and pharmacological evaluation of benzoindolizidine and benzoquinolizidine analogues of alpha- and beta-peltatin.
Couture A; Deniau E; Grandclaudon P; Lebrun S; Léonce S; Renard P; Pfeiffer B
Bioorg Med Chem; 2000 Aug; 8(8):2113-25. PubMed ID: 11003157
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of heteroaromatic 6,7-diaryl-2,3,8,8a-tetrahydroindolizin-5(1H)-ones for cytotoxicity against the HCT-116 colon cancer cell line.
Kimball FS; Himes RH; Georg GI
Bioorg Med Chem Lett; 2008 Jun; 18(11):3248-50. PubMed ID: 18479919
[TBL] [Abstract][Full Text] [Related]
18. Antitumor agents 253. Design, synthesis, and antitumor evaluation of novel 9-substituted phenanthrene-based tylophorine derivatives as potential anticancer agents.
Wei L; Shi Q; Bastow KF; Brossi A; Morris-Natschke SL; Nakagawa-Goto K; Wu TS; Pan SL; Teng CM; Lee KH
J Med Chem; 2007 Jul; 50(15):3674-80. PubMed ID: 17585747
[TBL] [Abstract][Full Text] [Related]
19. A novel 3-arylethynyl-substituted pyrido[2,3,-b]pyrazine derivatives and pharmacophore model as Wnt2/β-catenin pathway inhibitors in non-small-cell lung cancer cell lines.
Gong YD; Dong MS; Lee SB; Kim N; Bae MS; Kang NS
Bioorg Med Chem; 2011 Sep; 19(18):5639-47. PubMed ID: 21855350
[TBL] [Abstract][Full Text] [Related]
20. Pyrrolizine/Indolizine-NSAID Hybrids: Design, Synthesis, Biological Evaluation, and Molecular Docking Studies.
Abourehab MAS; Alqahtani AM; Almalki FA; Zaher DM; Abdalla AN; Gouda AM; Beshr EAM
Molecules; 2021 Oct; 26(21):. PubMed ID: 34770990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
